We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$6.72B
AUM Growth
+$2.09B
Cap. Flow
+$3.09B
Cap. Flow %
45.88%
Top 10 Hldgs %
32.49%
Holding
567
New
175
Increased
115
Reduced
87
Closed
155

Sector Composition

Rank Sector Weight
1 Consumer Staples 24%
2 Consumer Discretionary 11.42%
3 Communication Services 10.85%
4 Industrials 8.56%
5 Technology 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
476
ExxonMobil
XOM
$642B
-210,238
Closed -$19.7M
XOP icon
477
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.52B
-15,375
Closed -$27K
YELP icon
478
Yelp
YELP
$1.38B
-62,500
Closed -$1.9M
TEN
479
Tsakos Energy Navigation Ltd
TEN
$1.18B
-20,000
Closed -$469K
NVRO
480
DELISTED
NEVRO CORP.
NVRO
-16,800
Closed -$1.24M
SWN
481
DELISTED
Southwestern Energy Company
SWN
-1,546,353
Closed -$19.5M
GOL
482
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-433,005
Closed -$917K
ICPT
483
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-14,919
Closed -$2.13M
PRTK
484
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-40,000
Closed -$556K
ISEE
485
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-20,000
Closed -$1.02M
OTIC
486
DELISTED
Otonomy, Inc.
OTIC
-40,000
Closed -$635K
GBT
487
DELISTED
Global Blood Therapeutics, Inc.
GBT
-50,000
Closed -$830K
SREV
488
DELISTED
ServiceSource International, Inc.
SREV
-621,328
Closed -$2.5M
XENT
489
DELISTED
Intersect ENT, Inc
XENT
-70,000
Closed -$905K
FLXN
490
DELISTED
Flexion Therapeutics, Inc.
FLXN
-75,000
Closed -$1.12M
STAY
491
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
-267,250
Closed -$4M
OXFD
492
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-50,705
Closed -$456K
GPOR
493
DELISTED
Gulfport Energy Corp.
GPOR
-18,626
Closed -$582K
ZAYO
494
DELISTED
Zayo Group Holdings, Inc.
ZAYO
-173,000
Closed -$4.83M
DERM
495
DELISTED
Dermira, Inc.
DERM
-55,443
Closed -$1.62M
GNMX
496
DELISTED
Aevi Genomic Medicine Inc
GNMX
-50,000
Closed -$278K
ONCE
497
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-20,000
Closed -$1.02M
ALDR
498
DELISTED
Alder Biopharmaceuticals
ALDR
-55,000
Closed -$1.37M
WP
499
DELISTED
Worldpay, Inc.
WP
-75,901
Closed -$4.3M
WFT
500
CALL
DELISTED
Weatherford International plc
WFT
-375,000
Closed -$8K

Similar funds

UBS O'Connor's Q3 2016 Portfolio in Review

As of Q3 2016, UBS O'Connor held 567 positions worth $6.72B, up 45% from $4.64B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

UBS O'Connor deployed $3.09B of net new capital in Q3 2016, opening 175 new positions and adding to 115 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 4,425,977 shares worth $166M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Kellanova, an estimated $28M trimmed.

  • UBS O'Connor's largest Q3 2016 buy was iShares MSCI Emerging Markets ETF: 4,425,977 shares worth $166M.
  • UBS O'Connor added most to Procter & Gamble in Q3 2016, an estimated $693M increase.
  • UBS O'Connor's biggest Q3 2016 reduction was Kellanova, cutting an estimated $28M.
  • UBS O'Connor fully exited EMC CORPORATION in Q3 2016, selling an estimated $218M.
  • UBS O'Connor's ten largest holdings make up 32% of its $6.72B portfolio in Q3 2016.
  • UBS O'Connor opened 175 new positions and closed 155 in Q3 2016.
  • UBS O'Connor's portfolio value rose 45% quarter-over-quarter to $6.72B.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.